| Glial fibrillary acidic protein autoimmunity: a French cohort study A Gravier-Dumonceau, R Ameli, V Rogemond, A Ruiz, B Joubert, ... Neurology 98 (6), e653-e668, 2022 | 113 | 2022 |
| COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF D Andriuta, PA Roger, W Thibault, B Toublanc, C Sauzay, S Castelain, ... Journal of Neurology 267, 2810-2811, 2020 | 65 | 2020 |
| Added value of 18F‐florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study M Ceccaldi, T Jonveaux, A Verger, P Krolak‐Salmon, C Houzard, ... Alzheimer's & Dementia 14 (3), 293-305, 2018 | 61 | 2018 |
| Is reaction time slowing an early sign of Alzheimer’s disease? A meta-analysis D Andriuta, M Diouf, M Roussel, O Godefroy Dementia and Geriatric Cognitive Disorders 47 (4-6), 281-288, 2019 | 44 | 2019 |
| Clinical and imaging determinants of neurocognitive disorders in post-acute COVID-19 patients with cognitive complaints D Andriuta, C Si-Ahmed, M Roussel, JM Constans, M Makki, A Aarabi, ... Journal of Alzheimer’s Disease 87 (3), 1239-1250, 2022 | 26 | 2022 |
| Differentiating between Alzheimer’s disease and vascular cognitive impairment: is the “memory versus executive function” contrast still relevant? D Andriuta, M Roussel, M Barbay, S Despretz-Wannepain, O Godefroy, ... Journal of Alzheimer’s Disease 63 (2), 625-633, 2018 | 22 | 2018 |
| Imaging characteristics of venous parenchymal abnormalities A Arnoux, A Triquenot-Bagan, D Andriuta, D Wallon, ... Stroke 48 (12), 3258-3265, 2017 | 19 | 2017 |
| Isolated parkinsonism is an atypical presentation of GRN and C9orf72 gene mutations F Carneiro, D Saracino, V Huin, F Clot, C Delorme, A Méneret, S Thobois, ... Parkinsonism & Related Disorders 80, 73-81, 2020 | 16 | 2020 |
| Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screening G Nicolas, A Zaréa, M Lacour, O Quenez, S Rousseau, AC Richard, ... Genetics in Medicine 26 (5), 101082, 2024 | 10 | 2024 |
| Functional architecture of executive processes: evidence from verbal fluency and lesion mapping in stroke patients O Godefroy, A Aarabi, F Dorchies, M Barbay, D Andriuta, M Diouf, ... Cortex 164, 129-143, 2023 | 10 | 2023 |
| Poststroke action slowing: Motor and attentional impairments and their imaging determinants. Evidence from lesion-symptom mapping, disconnection and fMRI activation studies E Ouin, M Roussel, A Aarabi, A Arnoux, S Tasseel-Ponche, D Andriuta, ... Neuropsychologia 177, 108401, 2022 | 10 | 2022 |
| Poststroke apathy: major role of cognitive, depressive and neurological disorders over imaging determinants M Aubignat, M Roussel, A Aarabi, C Lamy, D Andriuta, S Tasseel-Ponche, ... Cortex 160, 55-66, 2023 | 8 | 2023 |
| What are the most frequently impaired markers of neurodegeneration in ADNI subjects? D Andriuta, V Moullart, S Schraen, A Devendeville, ME Meyer, O Godefroy Journal of Alzheimer’s Disease 51 (3), 793-800, 2016 | 7 | 2016 |
| Episodic headache with spontaneous hypothermia reveal Shapiro’s syndrome variant with effectiveness of clonidine therapy M Aubignat, M Tir, P Krystkowiak, D Andriuta The Journal of Headache and Pain 22 (1), 30, 2021 | 5 | 2021 |
| Global hypoactivity and apathy O Godefroy, M Barbay, D Andriuta, M Tir, M Roussel Neuropsychiatric symptoms of cognitive impairment and dementia, 71-91, 2017 | 3 | 2017 |
| Huntington's Disease Revealed by Familial Cervical Dystonia D Andriuta, M Tir, O Godefroy, P Krystkowiak Movement disorders clinical practice 3 (4), 415, 2016 | 3 | 2016 |
| Teaching NeuroImages: Epilepsia partialis continua revealing PML after allogenic stem cell transplantation D Andriuta, M Tir, B Perin, PE Merle, C Bryer-Le Breton, A Charbonnier, ... Neurology 85 (5), e53-e54, 2015 | 3 | 2015 |
| Poststroke cognitive outcome is better accounted for by white matter abnormalities automated segmentation than visual analysis B Lawson, J Martin, A Aarabi, E Ouin, S Tasseel-Ponche, M Barbay, ... Revue Neurologique 180 (10), 1117-1127, 2024 | 2 | 2024 |
| In individuals with subjective cognitive decline, age, memory and speed scores at baseline predict progression to cognitive impairment A Perron, M Roussel, S Wannepain-Despretz, M Barbay, A Devendeville, ... Alzheimer Disease & Associated Disorders 36 (4), 359-361, 2022 | 2 | 2022 |
| Inferior parietal cortex hypoperfusion is the most specific imaging marker for AD patients with positive CSF biomarker assays in a memory clinic in France D Andriuta, V Moullart, S Schraen, A Devendeville, ME Meyer, O Godefroy Alzheimer Disease & Associated Disorders 32 (2), 89-93, 2018 | 2 | 2018 |
